European Journal of Clinical Pharmacology

, Volume 23, Issue 2, pp 99–106 | Cite as

Plasma concentrations and haemodynamic effects of nitroglycerin during and after intravenous infusion in healthy volunteers

  • P. R. Imhof
  • A. Sieber
  • J. Hodler
  • P. Müller
  • B. Ott
  • P. Fankhauser
  • L. -C. Chu
  • A. Gérardin


The effects of nitroglycerin, infused intravenously at 3.4 and 7.5 µg/min over 30 min, on haemodynamic parameters were determined in the morning and the afternoon in a randomized, placebo-controlled study in 5 healthy volunteers. The mean steady-state concentrations of nitroglycerin reached in the plasma during the infusions of 3.4 and 7.5 µg/min were 0.35±0.06 ng/ml and 0.64±0.22 ng/ml, respectively. Wide inter-individual variation was noted. The nitroglycerin-induced increase in the orthostatic rise in heart rate and the change in digital-pulse-wave morphology roughly paralleled the plasma concentration, whereas the reduction in systolic blood pressure in the upright position was still evident 15 mins after the infusion, i.e. when nitroglycerin was no longer measurable in plasma. No significant diurnal variation in vascular sensitivity to the vasodilative action of nitroglycerin was demonstrable. The change in pulse-wave morphology resulting from the reduction in peripheral resistance (shift of the dicrotic wave in the descending limb towards the base-line) proved to be the most sensitive haemodynamic parameter.

Key words

nitroglycerin i.v. infusion plasma level haemodynamic effects 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Christensen B, Nordenfelt I, Westling H, White T (1969) Intravenous infusion of nitroglycerin in normal subjects. Scand J Clin Lab Invest 23: 49–53Google Scholar
  2. 2.
    Flaherty JT, Come PC, Baird MD, Rouleau J, Taylor DR, Weisfeldt ML, Greene HL, Becker LC, Pitt B (1976) Effects of intravenous nitroglycerin on left ventricular function and ST segment changes in acute myocardial infarction. Br Heart J 38: 612–621Google Scholar
  3. 3.
    Hergott L, Amsterdam EA, Klein R, Licht J, Joye JA, DeMaria AN, Mason DT (1979) Hemodynamic effects of intravenous nitroglycerin compared to nitroprusside in acute cardiac failure. Clin Res 27: 16AGoogle Scholar
  4. 4.
    Strauer BE, Scherpe A (1978) Ventricular function and coronary hemodynamics after intravenous nitroglycerin in coronary artery disease. Am Heart J 95: 210–219Google Scholar
  5. 5.
    Armstrong PW, Armstrong JA, Marks GS (1980) Pharmacokinetic-hemodynamic studies of intravenous nitroglycerin in congestive cardiac failure. Circulation 62: 160–166Google Scholar
  6. 6.
    Armstrong PW, Armstrong JA, Marks GS (1980) Plasma nitroglycerin gradient during intravenous infusion in man. Circulation 62: 111–326; Clin Res 28: 662AGoogle Scholar
  7. 7.
    Oh VMS, Reid PR (1979) Pharmacodynamic studies after intravenous trinitroglycerin. Pharmacologist 21: 202 (Abstr)Google Scholar
  8. 8.
    Oh VMS, Reid PR Pharmacodynamic studies following intravenous trinitroglycerin. Clin Res 27: 191 A (Abstr)Google Scholar
  9. 9.
    Wei JY, Reid PR (1979) Quantitative determination of trinitroglycerin in human plasma. Circulation 59: 588–592Google Scholar
  10. 10.
    McNiff EF, Yacobi A, Young-Chang FM, Golden LH, Goldfarb A, Fung H-L (1981) Nitroglycerin pharmacokinetics after intravenous infusion in normal subjects. J Pharm Sci 70: 1054–1058Google Scholar
  11. 11.
    Imhof PR, Ott B, Fankhauser P, Chu L-C, Hodler J (1980) Difference in nitroglycerin dose-response in the venous and arterial beds. Eur J Clin Pharmacol 18: 455–460Google Scholar
  12. 12.
    Imhof PR, Ott B, Weiss A, Chu L-C, Chasseaud LR (1981) Plasma concentrations and hemodynamic effects of percutaneously administered nitroglycerin and isosorbide dinitrate in healthy volunteers. In: Lichtlen PR, Engel HJ, Schrey A, Swan HJC (eds), Nitrates III. Cardiovascular Effects. Springer, Berlin Heidelberg New York, pp 66–74Google Scholar
  13. 13.
    Yap PSK, McNiff EF, Fung H-L (1978) An improved GLC assay for the determination of nitroglycerin in plasma. J Pharm Sci 67: 582–584Google Scholar
  14. 14.
    Gérardin A, Gaudry D, Wantiez D (1982) Gas-chromatography mass-spectrometry determination of 1, 2, 3-propanetriol-trinitrate (nitroglycerin) in human plasma using the nitrogen-15 labelled compound as internal standard. Biom Mass Spectrom (in press)Google Scholar
  15. 15.
    Müller Ph, Imhof PR, Burkart F, Chu L-C, Gérardin A (1982) Human pharmacological studies of a new transdermal system containing nitroglycerin. Eur J Clin Pharmacol (in press)Google Scholar
  16. 16.
    Baaske DM, Ammann AH, Wagenknecht DM, Mooers M, Carter JE, Hoyt HJ, Stoll RG (1980) Nitroglycerin compatibility with intravenous fluid filters, containers, and administration sets. Am J Hosp Pharm 37:201–205Google Scholar
  17. 17.
    Branje, JPhA, Berghuis B (1980) Adsorption of NTG. Am Heart J 100:409–410Google Scholar
  18. 18.
    Ingram JK, Miller JD (1979) Plastic absorption adsorption of nitroglycerin in solution. Anesthesiology 51 [Suppl]:132Google Scholar
  19. 19.
    Sokoloski ThD, Wu C-C, Burkman AM (1980) Rapid adsorptive loss of nitroglycerin from aqueous solution to plastic. Int J Pharmaceut 6:63–76Google Scholar
  20. 20.
    Yuen P-H, Denman SL, Sokoloski ThD, Burkman AM (1979) Loss of nitroglycerin from aqueous solution into plastic intravenous delivery systems. J Pharm Sci 68:1163–1166Google Scholar
  21. 21.
    Brymer JF, Stetson PL, Walton JA, Lucchesi BR, Pitt B (1979) Correlation of hemodynamic effects and plasma levels of nitroglycerin. Clin Res 27:229AGoogle Scholar
  22. 22.
    Kamiya A, Fung HL (1981) In: Abstracts of papers presented before the APhA Academy of Pharmaceutical Sciences. 11:78 (quoted from Reference 10)Google Scholar
  23. 23.
    Armstrong JA, Slaughter SE, Marks GS, Armstrong PW (1980) Rapid disappearance of nitroglycerin following incubation with human blood. Can J Physiol Pharmacol 58:459–462Google Scholar
  24. 24.
    Packer M, Meller J, Medina N, Yushak M, Gorlin R (1981) Determinants of drug response in severe chronic heart failure. 1. Activation of vasoconstictor forces during vasodilator therapy. Circulation 64:506–514Google Scholar
  25. 25.
    Bussmann W-D, Schöfer H, Kurita A, Ganz W (1979) Nitroglycerin in acute myocardial infarction. X. Effect of small and large doses of nitroglycerin on sigma ST segment deviation.-Experimental and clinical results. Clin Cardiol 2:106–112Google Scholar

Copyright information

© Springer-Verlag 1982

Authors and Affiliations

  • P. R. Imhof
    • 1
  • A. Sieber
    • 2
  • J. Hodler
    • 2
  • P. Müller
    • 1
  • B. Ott
    • 1
  • P. Fankhauser
    • 1
  • L. -C. Chu
    • 3
  • A. Gérardin
    • 4
  1. 1.Research Department, Pharmaceuticals DivisionCIBA-GEIGY LimitedBasleSwitzerland
  2. 2.Clinical Pathology Unit, Medical Out-patient ClinicUniversity of BerneSwitzerland
  3. 3.ALZA Research DivisionALZA CorporationPalo AltoUSA
  4. 4.the Biopharmaceutical Research CentreCIBA-GEIGY LimitedRueil-MalmaisonFrance

Personalised recommendations